🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Taylor Karl presenting our modeling data suggesting that fecal calprotectin monitoring reduces costs and improves quality of life in comparison to colonoscopic assessment in low risk post operative CD, supporting recently published guideline revisions Ben Click CU Division of Gastroenterology and Hepatology

#TaylorKarl with an outstanding presentation evaluating the cost-effectiveness of #calprotectin in post-op #CD monitoring. Ben Click Frank I Scott, MD MSCE Benjamin Cohen MD MAS Jordan Axelrad, MD, MPH Miguel Regueiro #DDW2024

Thanks to Shomron Ben-Horin for phenomenal talk on role of VCE - practice changing evidence from master clinician, researcher, and world traveler.

Hot of the press: Upadacitinib safety in pregnancy. 128 maternal pregnacies all exposed in the first trimester primarily. MotherToBaby Mette Julsgaard Millie Long link.springer.com/article/10.100…

It’s dope to scope! 🤣First year fellows start scoping right away on inpatient consult services and on outpatient endo blocks. Follow our fellows on instagram @colorado_gi #futureofgi #gifellowship #gifellows #gastroenterology #academicgi

Kudos to Stefan Holubar MD MS for the excellent mesenteric landscape breakdown. SPICY trial an important addition, but still many unknowns in “trimming the Crohn’s fat” CU Division of Gastroenterology and Hepatology Cleveland Clinic

It’s a packed 🏡 at #RMH2024! We are so thankful 🙌 for all of our amazing attendees and supporters for coming out bright ⭐️ and early 🌞on this Saturday!

🚨Fellows & jr attendings- Don't miss this on 9/18! 1⃣Find & negotiate your first or next GI/#IBD job, academic or community 2⃣Navigate career transitions or move to leadership 3⃣Q&A with those in the know @drharrythomas Raymond Cross Jill Gaidos, MD Ben Click Sign up 👇

Audrey Bennett, MD did an amazing job at #ACG2024 presenting a multi-center study evaluating outcomes in transgender pts with IBD on gender affirming hormones! @VUMCibd Victor Chedid, MD Kira Newman, MD, PhD @JustinFieldMD Ben Click

More RWE that combo-AT effective in refractory IBD (n=79) Jennifer Seminerio 🟢Mean Mayo 3▶️1 🟢Mean SES-CD 12▶️4 🟢73% clin improvement 🔴47% AEs (URIs and derm issues mostly) bit.ly/4fm80WI

First non aTNF to demonstrate efficacy in RCT to 🛑 endo recurrence. Good option and reassuring data to have.

🚨AGA New Guideline Alert🚨 🔗gastrojournal.org/article/S0016-… ▶️AGA Living Guideline: Pharmacological Management of Moderate-Severe Ulcerative Colitis I’ll break down its 14 recommendations down over the next 7 tweets 🧵 👇 #AGA #GI #UC #IBD #MedTwitter 1/9

Makes sense and highlights 💊💉needs after ASUC 🏥, but still high (~50%) rate of “treatment failure” in IVCS responsive -> IFX + AZA. ? rapid steroid taper in IFX. ? No proactive TDM in high risk pop. Other thoughts? Waseem Ahmed Jeffrey Berinstein Shrinivas Bishu

Maybe time to just get the C diff test?

Crowdsourcing IBD journal club ideas. What are your biggest clinical impact recent articles? David Fudman, MD Aline Charabaty, MD, FACG, AGAF Shrinivas Bishu Waseem Ahmed Edward Loftus Millie Long Beatriz Gros

‼️Important HBV reaction prevention in IBD pts. Note JAKi mod risk > aTNF in sAg(-), cAb(+) -> antiviral ppx. Shubha Bhat, PharmD Jana G Hashash, MD, MSc David Fudman, MD Waseem Ahmed David Choi, PharmD gastrojournal.org/article/S0016-…